Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

May 2, 2035

Study Completion Date

May 2, 2035

Conditions
Non Small Cell Lung CancerStage IIIA Lung CancerStage IIIB Lung Cancer
Interventions
DRUG

Atezolizumab

Patients will receive atezolizumab administered by intravenous infusion in a monitored setting where there is immediate access to trained personnel and adequate equipment/medicine to manage potentially serious reactions.

DRUG

Paclitaxel

"Neoadjuvant / induction treatment:~Atezolizumab Paclitaxel Carboplatin~Neoadjuvant / induction treatment 3 cycles will be administered prior to the assessment for surgery.~Route of administration Paclitaxel: Intravenous infusion.~Guidelines of Paclitaxel administration: Paclitaxel must be administered by infusion over 3 hours in dextrose (D5W) or normal saline (NS). The concentration must not exceed 1.2 mg/ml."

DRUG

Carboplatin

"Neoadjuvant / induction treatment:~Atezolizumab Paclitaxel Carboplatin\*~\*Infusion according to the standard of each center~Neoadjuvant / induction treatment 3 cycles will be administered prior to the assessment for surgery.~Route of administration Carboplatin: Intravenous infusion. Guidelines of Carboplatin administration: According to the standard of each center."

Trial Locations (21)

11407

NOT_YET_RECRUITING

Hospital Univ. De Jerez De La Frontera, Jerez de la Frontera

15006

RECRUITING

Hospitalario Universitario A Coruña, A Coruña

17007

RECRUITING

ICO Girona, Hospital Josep Trueta, Girona

18007

NOT_YET_RECRUITING

Hospital Universitario Clinico San Cecilio, Granada

23007

NOT_YET_RECRUITING

Hospital Universitario de Jaén, Jaén

27003

NOT_YET_RECRUITING

Hospital Universitario Lucus Augusti, Lugo

28040

NOT_YET_RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

28222

NOT_YET_RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

31008

NOT_YET_RECRUITING

Complejo Hospitalario de Navarra, Pamplona

35010

NOT_YET_RECRUITING

Hospital Universitari de Gran Canària Doctor Negrín, Las Palmas de Gran Canaria

37007

RECRUITING

Hospital Universitario Salamanca, Salamanca

38009

NOT_YET_RECRUITING

Hospital Universitario Nuestra Señora La Candelaria, Santa Cruz de Tenerife

41013

NOT_YET_RECRUITING

Hospital Universitario Virgen Del Rocio, Seville

46014

NOT_YET_RECRUITING

Hospital General Universitario de Valencia, Valencia

48013

RECRUITING

Hospital De Basurto, Bilbao

03010

RECRUITING

Hospital General Universitario Dr. Balmis de Alicante, Alicante

08916

RECRUITING

ICO Badalona, Hospital Germans Trias i Pujol, Badalona

08035

NOT_YET_RECRUITING

Hospital Universitari Vall d' Hebron, Barcelona

08041

NOT_YET_RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

08208

NOT_YET_RECRUITING

Hospital Parc Taulí, Barcelona

07198

NOT_YET_RECRUITING

Hospital Universitari Son Llatzer, Palma de Mallorca

All Listed Sponsors
lead

Fundación GECP

OTHER

NCT07153445 - Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter